Related Experiment Video
Updated: Sep 21, 2026

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
Case Report: Acute Spinal Cord Myelopathy in Patients With COVID-19
Eman M Khedr1, Ahmed A Karim2, Radwa K Soliman3
1Department of Neuropsychiatry, Assiut University Hospitals, Assiut, Egypt.
Abstract:
COVID-19 is typically associated with fever and severe respiratory symptoms including dry cough and dyspnea. However, COVID-19 may also affect both central and peripheral nervous systems. To date, the incidence rate of spinal cord involvement in COVID-19 is not known and the pathogenesis is still not fully understood. We report here two female patients admitted to Assiut University Hospitals/Egypt during the period from first of July to August 10, 2020. Both presented with a positive SARS-CoV-2 polymerase chain reaction (PCR) nasopharyngeal swab, elevated serum d-dimer and ferritin levels, and bilateral ground glass appearance in a CT chest scan. The first was a 60-year-old female with acute onset of flaccid paraplegia 10 days after flu-like symptoms, in whom MRI revealed transverse myelitis. The second was a 21-year-old female with symptoms of acute quadriplegia, fever, headache, and anosmia in whom an MRI scan revealed long cervico-thoracic myelopathy. Anterior spinal artery occlusion and possibly transverse myelitis were considered as differential diagnosis of long segment myelopathy.
Related Concept Videos
Viral Meningitis
Poliomyelitis
Arboviral Encephalitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Secondary Spinal Cord Injury llI: Pathophysiology

